Novartis Still On Track to Buy Majority In Alcon

by Editor on December 7, 2008 in Asides

Novartis Chief Executive Daniel Vasella confirmed that Novartis is still on track to buy a majority share in Alcon in a report December 5, 2008 in Switzerland

Bookmark and Share

Related posts:

  1. From Allergan To Advanced Medical Optics To Abbott In 7 Years
  2. Alcon second-quarter profit rises 26 pct
  3. Dan Pritchard – International Pharmaceuticals and Medical Device Industries Management Consultant
  4. BD (Becton Dickinson) On A Roll
  5. Homecare Sales Mid 2010 Reflect Renewed Growth – From Wheelchairs To Sleep Apnea Products

Tags: ,

Post Author

This post was written by Editor who has written 96 posts on the international medical market place.

Trackbacks/Pingbacks

  1. From Allergan To Advanced Medical Optics To Abbott In 7 Years — the international medical market place - January 12, 2009

    [...] Makes sense with one possible caveat – ophthalmology requires focus and the most successful companies have been largely independent. This changes with the Abbott acquisition, but also comes short on the heels of the new majority shareholding by Novartis in Alcon… [...]

Leave a Reply